Associated Papers
In a multi-institutional cohort of myeloid sarcomas, NFE2 mutation prevalence is lower than previously reported.
Anekpuritanang T et al.
Blood Advances, 2021
34559205 (PubMed )
Supplement: advancesADV2021004983-suppl1.pdf
Select a paper to view details